Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
- PMID: 24845191
- DOI: 10.1016/j.psyneuen.2014.03.013
Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Abstract
Background: Several studies have suggested that induced tryptophan (TRP) degradation through the kynurenine (KYN) pathway by the enzyme indoleamine 2,3-dioxygenase (IDO) is implicated in the relation between depression and inflammation. We investigated the role of tryptophan degradation in the relationship between inflammatory markers and depressive symptoms in the Netherlands Study of Depression and Anxiety (NESDA) and hypothesized that tryptophan degradation would mediate (part of) this association.
Methods: 2812 Participants of NESDA were included in this study including 1042 persons with current major depressive disorder (MDD). Assessments of C-reactive protein (CRP), interleukin (IL)-6, tumor-necrosis factor (TNF)-α, KYN and TRP were obtained from fasting blood samples at the baseline assessment. Tryptophan degradation was estimated by calculating the ratio [KYN/TRP]. Depressive symptoms were measured with the Inventory of Depressive Symptomatology.
Results: Significant associations between inflammation and depressive symptoms were found for CRP and IL-6, for the total group and the subgroup of patients with current MDD. Adjustment for KYN/TRP did not attenuate these associations. There were no significant indirect effects for CRP on depressive symptoms mediated by KYN/TRP for the whole group (B=-0.032; 95% CI: -0.103 to 0.028) and for the subgroup of patients with current MDD (B=0.059; 95% CI: -0.037 to 0.165). Also IL-6 did not indirectly affect depressive symptoms through KYN/TRP in the total group (B=-0.023; 95% CI: -0.093 to 0.045) and in the MDD subgroup B=0.052; 95% CI: -0.019 to 0.144). Finally, no significant relation between depressive symptoms and KYN/TRP was found in the whole group (β=-0.019, p=0.311) nor in the subgroup with MDD (β=0.025, p=0.424).
Conclusions: We did not find indications for tryptophan degradation, measured by KYN/TRP, to mediate the relationship between inflammation and depressive symptoms.
Keywords: Depression; Depressive symptoms; Indoleamine 2,3-dioxygenase; Inflammation; Kynurenine; Tryptophan.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
The role of tryptophan degradation in the association between inflammatory markers and depressive symptoms in chronic dialysis patients.Nephrol Dial Transplant. 2017 Jun 1;32(6):1040-1047. doi: 10.1093/ndt/gfw212. Nephrol Dial Transplant. 2017. PMID: 27220752
-
IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.Mol Psychiatry. 2005 Jun;10(6):538-44. doi: 10.1038/sj.mp.4001600. Mol Psychiatry. 2005. PMID: 15494706 Clinical Trial.
-
The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.Brain Behav Immun. 2015 Aug;48:48-52. doi: 10.1016/j.bbi.2015.02.029. Epub 2015 Mar 9. Brain Behav Immun. 2015. PMID: 25765557
-
A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.Stress. 2008 May;11(3):198-209. doi: 10.1080/10253890701754068. Stress. 2008. PMID: 18465467 Review.
-
The role and mechanism of tryptophan - kynurenine metabolic pathway in depression.Rev Neurosci. 2022 Sep 5;34(3):313-324. doi: 10.1515/revneuro-2022-0047. Print 2023 Apr 25. Rev Neurosci. 2022. PMID: 36054612 Review.
Cited by
-
Tryptophan catabolites and depression in the general population: results from the Gutenberg Health Study.BMC Psychiatry. 2023 Jan 11;23(1):27. doi: 10.1186/s12888-023-04520-6. BMC Psychiatry. 2023. PMID: 36631760 Free PMC article.
-
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.Curr Neuropharmacol. 2015;13(3):324-68. doi: 10.2174/1570159x13666150307004545. Curr Neuropharmacol. 2015. PMID: 26411964 Free PMC article. Review.
-
Sex Specific Changes in Tryptophan Breakdown Over a 6 Week Treatment Period.Front Psychiatry. 2019 Feb 21;10:74. doi: 10.3389/fpsyt.2019.00074. eCollection 2019. Front Psychiatry. 2019. PMID: 30846946 Free PMC article.
-
Aerobic Physical Exercise as a Non-medical Intervention for Brain Dysfunction: State of the Art and Beyond.Front Neurol. 2022 May 13;13:862078. doi: 10.3389/fneur.2022.862078. eCollection 2022. Front Neurol. 2022. PMID: 35645958 Free PMC article. Review.
-
The association between tryptophan levels and postpartum mood disorders: a systematic review and meta-analysis.BMC Psychiatry. 2022 Aug 8;22(1):539. doi: 10.1186/s12888-022-04178-6. BMC Psychiatry. 2022. PMID: 35941560 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous